- US12577581utility2026Use of Pre T Alpha or Functional Variant Thereof for Expanding TCR Alpha Deficient T Cells0 cites
- US12391933utility2025Targeted Gene Insertion for Improved Immune Cells Therapy0 cites
- US12365733utility2025Method for Improving Production of Car T Cells0 cites
- US12252699utility2025Method for Generating T-cells Compatible for Allogenic Transplantation0 cites
- US12221478utility2025Targeted Gene Integration of CRS Inhibitor Genes for Improved Immune Cells Therapy0 cites
- US12209125utility2025Targeted Gene Integration of NK Inhibitors Genes for Improved Immune Cells Therapy0 cites
- US12171820utility2024Method for Generating Immune Cells Resistant to Arginine And/or Tryptophan Depleted Microenvironment0 cites
- US12144825utility2024Cellular Immunotherapy for Repetitive Administration0 cites
- US12012607utility2024Engineering Wheat with Increased Dietary Fiber0 cites
- US11987639utility2024Trophoblast Glycoprotein (5T4, TPBG) Specific Chimeric Antigen Receptors for Cancer Immunotherapy0 cites
- US11959091utility2024Methods for Engineering T Cells for Immunotherapy by Using Rna-guided Cas Nuclease System0 cites
- US11919961utility2024CD123 Specific Chimeric Antigen Receptors for Cancer Immunotherapy0 cites
- US11903968utility2024Engineered Immune Cells Resistant to Tumor Microenvironment0 cites
- US11891614utility2024Methods for Engineering Allogeneic and Immunosuppressive Resistant T Cell for Immunotherapy0 cites
- US11873511utility2024Targeted Gene Insertion for Improved Immune Cells Therapy0 cites
- US11820996utility2023Method for Generating T-cells Compatible for Allogenic Transplantation0 cites
- US11692169utility2023Cells for Immunotherapy Engineered for Targeting Antigen Present Both on Immune Cells and Pathological Cells0 cites
- US11685935utility2023Compact Scaffold of Cas9 in the Type II CRISPR System0 cites
- US11674155utility2023Sequential Gene Editing in Primary Immune Cells0 cites
- US11624072utility2023Canola with High Oleic Acid0 cites
Page 1 of 2Next →